Transposons, or “jumping genes” – DNA segments that can move from one part of the genome to another – are key to bacterial evolution and the development of antibiotic resistance.
Daiichi Sankyo-AstraZeneca’s ENHERTU gains FDA BTD status
With the latest BTD, ENHERTU has now received eight designations, four of which are for metastatic breast cancer. Credit: Peakstock/Shutterstock. Daiichi Sankyo and AstraZeneca‘s ENHERTU
August 19, 2024